Regulatory

Regulatory  ·  Type 1 Diabetes
Tidepool’s automated insulin dosing app for management of T1D filed with FDA

Type 1 Diabetes – January 2021 Type 1 Diabetes – January 2021 Tidepool completes FDA submission of Tidepool Loop an automated insulin dosing app for management of Type 1 Diabetes (T1D) 07 Jan 2021 Tidepool Loop (automated insulin dosing app) […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Type 1 Diabetes
BLA filed for Provention Bio’s Teplizumab for T1D

Type 1 Diabetes – January 2021 Type 1 Diabetes – January 2021 Provention Bio announced U.S. FDA filing of a biologics license application (BLA) and priority review for Teplizumab for the delay or prevention of clinical Type 1 Diabetes in […]

by Sandhya Ramalingam

Continue Reading